Net Cash Provided by (Used in) Operating Activities |
644K |
USD |
+54.2% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-1.15M |
USD |
|
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-665K |
USD |
-1344% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
10M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
4.59M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0.1 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-1.17M |
USD |
-415% |
Q1 2024 |
Q1 2024 |
Payments to Acquire Property, Plant, and Equipment |
22K |
USD |
+750% |
Q1 2024 |
Q1 2024 |
Property, Plant and Equipment, Gross |
7.8M |
USD |
+3.3% |
Q2 2024 |
Q2 2024 |
Deferred Income Tax Expense (Benefit) |
70.6K |
USD |
|
Q1 2024 |
Q1 2024 |
Deferred Federal Income Tax Expense (Benefit) |
-73.4K |
USD |
-1017% |
Q2 2024 |
Q2 2024 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q4 2023 |
FY 2023 |
Current State and Local Tax Expense (Benefit) |
763 |
USD |
-56.1% |
Q2 2024 |
Q2 2024 |
Current Federal Tax Expense (Benefit) |
916K |
USD |
+63.8% |
Q2 2024 |
Q2 2024 |
Depreciation, Depletion and Amortization |
23.7K |
USD |
-3.04% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
487K |
USD |
-3.02% |
Q4 2023 |
FY 2023 |